Current role
Biotechnology · Healthcare
Chairman, Board Member
2026-05-21–present
James N. Wilson
Chairman
Corcept Therapeutics Inc (CORT)Board Member
Corcept Therapeutics Inc (CORT)Equibles does not estimate personal net worth.
Get an email with a short summary when Corcept Therapeutics Inc publishes a filing, an earnings call transcript or a press release.
Get CORT alertsAbout James N. Wilson
James N. Wilson is recorded as Board Member at Corcept Therapeutics Inc (CORT) since May 21, 2026 and Chairman at Corcept Therapeutics Inc (CORT). The newest filing on record that lists James N. Wilson as Chairman at Corcept Therapeutics Inc (CORT) is dated April 17, 2026. Corcept Therapeutics Inc reported in an 8-K filed May 28, 2026 that James N. Wilson was appointed director, effective May 21, 2026. Corcept Therapeutics Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Corcept Therapeutics Inc includes Joseph K. Belanoff (CEO and Board Member), Atabak Mokari (CFO), Joshua M. Murray (CFO, Head of Investor Relations and Board Member) and 7 others.
“James N. Wilson | 72,730,017 | 4,564,440 | 15,975,718”
Affiliation history
-
Current
2026-05-21–present
-
Current
Start not stated–present
Last confirmed April 17, 2026
Company network
Leadership on record at Corcept Therapeutics Inc
- Joseph K. Belanoff CEO, Board Member
- Atabak Mokari CFO
- Joshua M. Murray CFO, Head of Investor Relations, Board Member
- Daniel N. Swisher COO
- J.D. Lyon Chief Accounting Officer
- Joseph D. Lyon Chief Accounting Officer
- Daniel N. Swisher, Jr. Board Member
- David L. Mahoney Board Member
- G. Leonard Baker, Jr. Board Member
- Gillian M. Cannon, PhD Board Member